Data as of Aug 16, 2026 · Based on 3,131,739 AI responses across 10,525 prompts · See how Parse measures this
BenchScibenchsci.comEMET is an agentic workbench for preclinical R&D that reasons through disease biology by unifying data, models, software, workflows, and lab‑in‑the‑loop reasoning into a single environment. It relies on a proprietary knowledge graph with hundreds of millions of nodes and billions of relationships, plus access to millions of closed- and open-access papers, patents, and other datasets to yield traceable, explainable, and actionable insights for hypothesis generation, target identification, experiment design, and lead optimization. Built by scientists for scientists, EMET is enterprise-grade, model-agnostic, and includes a dedicated PhD team to tailor workflows, manage change, and integrate with customers' data and regulatory needs.
Sources
benchsci.com shapes more of what AI says about BenchSci than any other source, at 33% of its citations.
youtube.com · atinary.com · hellobio.com
The market map
Biopharma Research Platforms and Services →Where AI ranks BenchSci
Excerpts where BenchSci appeared in the AI's answer
BenchSci Ascend Uses AI and knowledge graphs to support biomedical research workflows, including literature and experimental intelligence.
BenchSci is designed for preclinical drug discovery and experimental planning. Its core asset is a biomedical knowledge graph that integrates publications, clinical data, and proprietary internal datasets.
